An Icahn School of Medicine at Mount Sinai study sheds new light on some of the underlying neurobiological mechanisms of opioid addiction, which accounted for three-quarters of the more than 100,000 fatal drug overdoses in the United States in 2021.
Chiesi partners with Haisco to commercialise bronchiectasis drug – Pharmaceutical Technology
Share this article The collaboration will develop the HSK31858 candidate to treat respiratory diseases. Credit: mi-viri via Getty Images. Chiesi Group and Haisco Pharmaceutical have